BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 24803179)

  • 1. Meeting report--3rd Neuroblastoma Research Symposium, Liverpool, 6-7th November, 2013.
    Bell E; Chen L; Viprey VF; Blanchard GB
    Pediatr Blood Cancer; 2014 Sep; 61(9):1711-3. PubMed ID: 24803179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroblastoma progress on many fronts: the Neuroblastoma Research Symposium.
    Wylie L; Philpott A
    Pediatr Blood Cancer; 2012 Apr; 58(4):649-51. PubMed ID: 21922652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroblastoma: biology, prognosis, and treatment.
    Park JR; Eggert A; Caron H
    Pediatr Clin North Am; 2008 Feb; 55(1):97-120, x. PubMed ID: 18242317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progress in treatment and risk stratification of neuroblastoma: impact on future clinical and basic research.
    Øra I; Eggert A
    Semin Cancer Biol; 2011 Oct; 21(4):217-28. PubMed ID: 21798350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. At the frontier of progress for paediatric oncology: the neuroblastoma paradigm.
    Moreno L; Marshall LV; Pearson AD
    Br Med Bull; 2013; 108():173-88. PubMed ID: 24211816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroblastoma: biology and therapy.
    Matthay KK
    Oncology (Williston Park); 1997 Dec; 11(12):1857-66; discussion 1869-72, 1875. PubMed ID: 9436190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Origin and initiation mechanisms of neuroblastoma.
    Tsubota S; Kadomatsu K
    Cell Tissue Res; 2018 May; 372(2):211-221. PubMed ID: 29445860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prognosis of neuroblastoma in childhood. Methods of assessment and clinical use].
    Pérel Y; Valteau-Couanet D; Michon J; Lavrand F; Coze C; Bergeron C; Notz A; Plantaz D; Chastagner P; Bernard F; Thomas C; Rubie H
    Arch Pediatr; 2004 Jul; 11(7):834-42. PubMed ID: 15234382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperdiploidy plus nonamplified MYCN confers a favorable prognosis in children 12 to 18 months old with disseminated neuroblastoma: a Pediatric Oncology Group study.
    George RE; London WB; Cohn SL; Maris JM; Kretschmar C; Diller L; Brodeur GM; Castleberry RP; Look AT
    J Clin Oncol; 2005 Sep; 23(27):6466-73. PubMed ID: 16116152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in neuroblastoma.
    Bowen KA; Chung DH
    Curr Opin Pediatr; 2009 Jun; 21(3):350-6. PubMed ID: 19381091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progress towards personalized therapeutics: biologic- and risk-directed therapy for neuroblastoma.
    Gustafson WC; Matthay KK
    Expert Rev Neurother; 2011 Oct; 11(10):1411-23. PubMed ID: 21955198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroblastoma: biology, prognosis, and treatment.
    Park JR; Eggert A; Caron H
    Hematol Oncol Clin North Am; 2010 Feb; 24(1):65-86. PubMed ID: 20113896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroblastoma: molecular pathogenesis and therapy.
    Louis CU; Shohet JM
    Annu Rev Med; 2015; 66():49-63. PubMed ID: 25386934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Favorable prognosis for patients 12 to 18 months of age with stage 4 nonamplified MYCN neuroblastoma: a Children's Cancer Group Study.
    Schmidt ML; Lal A; Seeger RC; Maris JM; Shimada H; O'Leary M; Gerbing RB; Matthay KK
    J Clin Oncol; 2005 Sep; 23(27):6474-80. PubMed ID: 16116154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacotherapy of neuroblastoma.
    George RE; Diller L; Bernstein ML
    Expert Opin Pharmacother; 2010 Jun; 11(9):1467-78. PubMed ID: 20408767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Management strategy in neuroblastoma].
    Balwierz W
    Przegl Lek; 2004; 61 Suppl 2():3-8. PubMed ID: 15686038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody-based immunotherapy in high-risk neuroblastoma.
    Johnson E; Dean SM; Sondel PM
    Expert Rev Mol Med; 2007 Dec; 9(34):1-21. PubMed ID: 18081947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting outcomes for children with neuroblastoma.
    Vermeulen J; De Preter K; Mestdagh P; Laureys G; Speleman F; Vandesompele J
    Discov Med; 2010 Jul; 10(50):29-36. PubMed ID: 20670596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroblastoma.
    Schulte JH; Eggert A
    Crit Rev Oncog; 2015; 20(3-4):245-70. PubMed ID: 26349419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroblastoma in the very young child: biological considerations.
    Kemshead JT; Patel K; Phimister B
    Br J Cancer Suppl; 1992 Aug; 18():S102-5. PubMed ID: 1503919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.